Literature DB >> 10702606

Soybean isoflavones as an alternative to traditional hormone replacement therapy: are we there yet?

G L Burke1, M Z Vitolins, D Bland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10702606     DOI： 10.1093/jn/130.3.664S

Source DB:  PubMed          Journal:  J Nutr        ISSN： 0022-3166            Impact factor:   4.798


× No keyword cloud information.
  3 in total

Review 1.  Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.

Authors:  C R Sirtori
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Keith B Cox; Jian Liu; Liqun Tian; Stephen Barnes; Qinglin Yang; Philip A Wood
Journal:  Lab Invest       Date:  2009-09-07       Impact factor: 5.662

3.  The Effect of Soy Isoflavones on the Menopause Rating Scale Scoring in Perimenopausal and Postmenopausal Women: A Pilot Study.

Authors:  Marya Ahsan; Ayaz Khurram Mallick
Journal:  J Clin Diagn Res       Date:  2017-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.